These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32932920)

  • 21. Adult neurogenesis in neurodegenerative diseases.
    Winner B; Winkler J
    Cold Spring Harb Perspect Biol; 2015 Apr; 7(4):a021287. PubMed ID: 25833845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
    Davis MY; Keene CD; Jayadev S; Bird T
    J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
    Jabir NR; Firoz CK; Baeesa SS; Ashraf GM; Akhtar S; Kamal W; Kamal MA; Tabrez S
    CNS Neurosci Ther; 2015 Jan; 21(1):1-7. PubMed ID: 25399848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multitarget therapeutic strategies for Alzheimer's disease.
    Ibrahim MM; Gabr MT
    Neural Regen Res; 2019 Mar; 14(3):437-440. PubMed ID: 30539809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
    Róna-Vörös K; Weydt P
    Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic Regulation of DNA Methylation and Brain Functions.
    Xie J; Xie L; Wei H; Li XJ; Lin L
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.
    La Morgia C; Ross-Cisneros FN; Sadun AA; Carelli V
    Front Neurol; 2017; 8():162. PubMed ID: 28522986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Long Noncoding RNAs in Neurodegenerative Diseases.
    Wan P; Su W; Zhuo Y
    Mol Neurobiol; 2017 Apr; 54(3):2012-2021. PubMed ID: 26910817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.
    de Tommaso M; Arendt-Nielsen L; Defrin R; Kunz M; Pickering G; Valeriani M
    Behav Neurol; 2016; 2016():7576292. PubMed ID: 27313396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytes in neurodegenerative disease.
    Phatnani H; Maniatis T
    Cold Spring Harb Perspect Biol; 2015 Apr; 7(6):. PubMed ID: 25877220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory dysfunction in Parkinson's disease.
    Wszolek ZK; Markopoulou K
    Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease.
    Jin U; Park SJ; Park SM
    Exp Neurobiol; 2019 Oct; 28(5):554-567. PubMed ID: 31698548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.
    Brás IC; König A; Outeiro TF
    J Huntingtons Dis; 2019; 8(3):245-256. PubMed ID: 31322580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.
    Maszka P; Kwasniak-Butowska M; Cysewski D; Slawek J; Smolenski RT; Tomczyk M
    Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
    Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
    Front Neurol; 2017; 8():701. PubMed ID: 29312125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabotropic glutamate receptors and neurodegenerative diseases.
    Ribeiro FM; Vieira LB; Pires RG; Olmo RP; Ferguson SS
    Pharmacol Res; 2017 Jan; 115():179-191. PubMed ID: 27872019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Mar; 606(1):10-8. PubMed ID: 8096426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.